The ability of oxPTM-CII to interact with HLA-DRB1*04 may activate autoreactive T-cells or B-cells, as observed in RA, suggesting a possible cross-reactive mechanism in a subset of T1D patients. The gene discussed is HLA-DRB1; the disease is type 1 diabetes mellitus.